OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

[1]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[2]  C. Croce,et al.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.

[3]  A. Schetter,et al.  MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers , 2009, Proceedings of the National Academy of Sciences.

[4]  Yandan Yao,et al.  MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.

[5]  P. Sun,et al.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. , 2009, Biochemical and biophysical research communications.

[6]  Frank J. Slack,et al.  MicroRNAs and cancer: An overview , 2008, Cell cycle.

[7]  Bob Löwenberg,et al.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.

[8]  Shuomin Zhu,et al.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.

[9]  A. López-Guillermo,et al.  MicroRNA expression profiling in classic Hodgkin lymphoma. , 2008, Blood.

[10]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[11]  Sreenath V. Sharma,et al.  Oncogene addiction: setting the stage for molecularly targeted cancer therapy. , 2007, Genes & development.

[12]  Shamit Soneji,et al.  Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma , 2007, International journal of cancer.

[13]  Chris Sander,et al.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. , 2007, Blood.

[14]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[15]  A. Joe,et al.  Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy , 2006, Nature Clinical Practice Oncology.

[16]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[17]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. McMahon,et al.  An ES cell system for rapid, spatial and temporal analysis of gene function in vitro and in vivo , 2005, Nucleic acids research.

[19]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[20]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[21]  Y. Jan,et al.  Progenitor cell maintenance requires numb and numblike during mouse neurogenesis , 2002, Nature.

[22]  N. Harris,et al.  Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.

[23]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[24]  L A Herzenberg,et al.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Y. Chang,et al.  High frequency of normal DJH joints in B cell progenitors in severe combined immunodeficiency mice , 1993, The Journal of experimental medicine.

[26]  K. Yokoyama,et al.  Transcriptional control of the endogenous MYC protooncogene by antisense RNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  今井 雄一郎.  Caspase inhibitor ZVAD-fmk facilitates engraftment of donor hematopoietic stem cells in intra-bone marrow-bone marrow transplantation , 2010 .

[28]  A. Joe,et al.  Oncogene addiction. , 2008, Cancer research.

[29]  D. Tenen,et al.  Reversibility of acute B-cell leukaemia induced by BCR–ABL1 , 2000, Nature Genetics.

[30]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[31]  A. Kiraimamoto.  Disruption of overlapping transcripts in the ROSA bgeo 26 gene trap strain leads to widespread expression of b-galactosidase in mouse embryos and hematopoietic cells (antisenseyreporter geneytransplantation) , 1997 .